These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 14073943)

  • 1. [DETERMINATION OF COMPLEMENT COMPONENTS IN HUMAN SERUM].
    MASHKOV AV; MIKHAILOVA ZM; LEVINA LA
    Zh Mikrobiol Epidemiol Immunobiol; 1963 Jun; 40():84-91. PubMed ID: 14073943
    [No Abstract]   [Full Text] [Related]  

  • 2. The interchangeability of the complement components of different animal species in the hemolysis of sheep erythrocytes sensitized with rabbit amboceptor.
    RICE CE; CROWSON CN
    J Immunol; 1950 Aug; 65(2):201-10. PubMed ID: 15436999
    [No Abstract]   [Full Text] [Related]  

  • 3. Reticulocytes have a higher resistance to complement lysis than erythrocytes.
    Sadallah S; Hanno S; Schifferli JA
    Acta Haematol; 2010; 123(3):153-7. PubMed ID: 20185900
    [No Abstract]   [Full Text] [Related]  

  • 4. Serum-red cell interactions at low ionic strength: erythrocyte complement coating and hemolysis of paroxysmal nocturnal hemoglobinuria cells.
    Jenkins DE; Hartmann RC; Kerns AL
    J Clin Invest; 1967 May; 46(5):753-61. PubMed ID: 6025481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemolysis of normal human erythrocytes by autologous serum complement.
    Kitamura H; Nagano A; Kitano E
    Int Arch Allergy Immunol; 1993; 100(3):209-14. PubMed ID: 8453307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemolysis by the complement of tanned erythrocytes coated with cobra venom factor: a sensitive method to detect the alternative complement pathway activity of serum.
    Okada H; Tanaka H
    J Immunol Methods; 1981; 46(1):85-95. PubMed ID: 6793665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on immune human hemolysis. I. The kinetics of the Donath-Land-steiner reaction and the requirement for complement in the reaction.
    HINZ CF; PICKEN ME; LEPOW IH
    J Exp Med; 1961 Jan; 113(1):177-218. PubMed ID: 13714487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discriminating the hemolytic risk of blood type A plasmas using the complement hemolysis using human erythrocytes (CHUHE) assay.
    Cunnion KM; Hair PS; Krishna NK; Sass MA; Enos CW; Whitley PH; Maes LY; Goldberg CL
    Transfusion; 2017 Mar; 57(3):517-524. PubMed ID: 28000304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [HEMOLYSIS STUDIES WITH S35-LABELLED GUINEA PIG COMPLEMENT: ON THE SUBSTANCE INCREASE FOLLOWING BINDING OF THE 1ST AND 4TH COMPLEMENT COMPONENTS].
    OPFERKUCH W; MUELLER HG
    Z Hyg Infektionskr; 1963 Oct; 149():271-80. PubMed ID: 14095019
    [No Abstract]   [Full Text] [Related]  

  • 10. The determination of the resistance of amboceptor sensitized erythrocytes to lysis by complement (with a comparison of results gained by the 50% method and the haematocrit method).
    JORDAN FL; SCHLESINGER FG
    Acta Med Scand; 1955 Feb; 151(2):101-6. PubMed ID: 14349627
    [No Abstract]   [Full Text] [Related]  

  • 11. Trypsin-activated complex of human factor B with cobra venom factor (CVF), cleaving C3 and C5 and generating a lytic factor for unsensitized guinea pig erythrocytes. I. Generation of the activated complex.
    Miyama A; Kato T; Horai S; Yokoo J; Kashiba S
    Biken J; 1975 Dec; 18(4):193-204. PubMed ID: 1218074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shape changes of GSH-treated erythrocytes during complement-induced hemolysis.
    Matsumoto N; Hiroshige Y
    Tohoku J Exp Med; 1980 Oct; 132(2):199-205. PubMed ID: 7444943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Terminal stages of complement hemolysis: technical comment.
    Wirtz GH; Westfall SS
    Immunol Lett; 1981 Apr; 3(1):51-5. PubMed ID: 6792060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the complement attack mechanism in the fluid phase and its control by C567-INH: lysis of normal erythrocytes initiated by zymosan, endotoxin, and immune complexes.
    Lint TF; Behrends CL; Baker PJ; Gewurz H
    J Immunol; 1976 Nov; 117(5 Pt 1):1440-6. PubMed ID: 1002985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interchangeability of the complement components of different animal species. IV. In the hemolysis of rabbit erythrocytes sensitized with sheep antibody.
    RICE CE; BOULANGER P
    J Immunol; 1952 Feb; 68(2):197-205. PubMed ID: 14927924
    [No Abstract]   [Full Text] [Related]  

  • 16. Hemolysis of sheep erythrocytes in guinea pig serum deficient in the fourth component of complement. II. Evidence for involvement of C1 and components of the alternate complement pathway.
    May JE; Frank MM
    J Immunol; 1973 Dec; 111(6):1668-76. PubMed ID: 4750863
    [No Abstract]   [Full Text] [Related]  

  • 17. STUDIES ON THE INTERACTION BETWEEN THE RHEUMATOID FACTOR AND COMPLEMENT COMPONENTS ON SENSITIZED SHEEP ERYTHROCYTES.
    YOSHIDA S; HIRAMATSU S; FUJIKAWA K; NAGAKI K; INAI S; TANABE S
    Biken J; 1964 Dec; 7():157-9. PubMed ID: 14308865
    [No Abstract]   [Full Text] [Related]  

  • 18. [Studies on the mechanism of immune hemolysis: fixation of the 2d complement component].
    OPFERKUCH W; COLLI A; KLEIN P
    Z Hyg Infektionskr; 1961; 147():230-9. PubMed ID: 13731026
    [No Abstract]   [Full Text] [Related]  

  • 19. Hemolysis of human red cells by hemologous complement, in the presence of tannic acid.
    PECK JL; THOMAS L
    J Clin Invest; 1948 Jul; 27(4):552. PubMed ID: 18873833
    [No Abstract]   [Full Text] [Related]  

  • 20. Complement lysis of human erythrocytes. II. A unique interaction of human C8 and C9 with paroxysmal nocturnal hemoglobinuria erythrocytes.
    Packman CH; Rosenfeld SI; Jenkins DE; Leddy JP
    J Immunol; 1980 Jun; 124(6):2818-23. PubMed ID: 7189536
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.